Zobrazeno 1 - 10
of 1 255
pro vyhledávání: '"Danahay, H."'
Autor:
Danahay H; Enterprise Therapeutics, Sussex Innovation Centre, University of Sussex, Science Park Square, Falmer, Brighton, BN1 9SB, United Kingdom., Gosling M; Enterprise Therapeutics, Sussex Innovation Centre, University of Sussex, Science Park Square, Falmer, Brighton, BN1 9SB, United Kingdom., Fox R; Sussex Drug Discovery Centre, School of Life Sciences, University of Sussex, BN1 9RH, United Kingdom., Lilley S; Sussex Drug Discovery Centre, School of Life Sciences, University of Sussex, BN1 9RH, United Kingdom., Charlton H; Sussex Drug Discovery Centre, School of Life Sciences, University of Sussex, BN1 9RH, United Kingdom., Hargrave JD; Evotec UK, 114 Innovation Drive, Milton Park, Abingdon, Oxfordshire OX14 4RZ, United Kingdom., Schofield TB; Evotec UK, 114 Innovation Drive, Milton Park, Abingdon, Oxfordshire OX14 4RZ, United Kingdom., Hay DA; Evotec UK, 114 Innovation Drive, Milton Park, Abingdon, Oxfordshire OX14 4RZ, United Kingdom., Went N; Evotec UK, 114 Innovation Drive, Milton Park, Abingdon, Oxfordshire OX14 4RZ, United Kingdom., McMahon P; Evotec UK, 114 Innovation Drive, Milton Park, Abingdon, Oxfordshire OX14 4RZ, United Kingdom., Marlin F; Evotec UK, 114 Innovation Drive, Milton Park, Abingdon, Oxfordshire OX14 4RZ, United Kingdom., Scott J; Evotec UK, 114 Innovation Drive, Milton Park, Abingdon, Oxfordshire OX14 4RZ, United Kingdom., Vile J; Evotec UK, 114 Innovation Drive, Milton Park, Abingdon, Oxfordshire OX14 4RZ, United Kingdom., Hewison S; Evotec UK, 114 Innovation Drive, Milton Park, Abingdon, Oxfordshire OX14 4RZ, United Kingdom., Ellam S; Evotec UK, 114 Innovation Drive, Milton Park, Abingdon, Oxfordshire OX14 4RZ, United Kingdom., Brown S; Evotec UK, 114 Innovation Drive, Milton Park, Abingdon, Oxfordshire OX14 4RZ, United Kingdom., Sabater J; Department of Research, Mount Sinai Medical centre, 4300 Alton Rd, Miami Beach FL 3340, USA., Kennet G; Saretius, Whiteknights House (B10), University of Reading, Reading, RG6 6UR, United Kingdom., Lightowler S; Saretius, Whiteknights House (B10), University of Reading, Reading, RG6 6UR, United Kingdom., Collingwood SP; Enterprise Therapeutics, Sussex Innovation Centre, University of Sussex, Science Park Square, Falmer, Brighton, BN1 9SB, United Kingdom. Electronic address: steve@enterprisetherapeutics.com.
Publikováno v:
European journal of medicinal chemistry [Eur J Med Chem] 2025 Jan 15; Vol. 282, pp. 117040. Date of Electronic Publication: 2024 Nov 08.
Autor:
Rowe SM, Jones I, Dransfield MT, Haque N, Gleason S, Hayes KA, Kulmatycki K, Yates DP, Danahay H, Gosling M, Rowlands DJ, Grant SS
Publikováno v:
International Journal of COPD, Vol Volume 15, Pp 2399-2409 (2020)
Steven M Rowe,1 Ieuan Jones,2 Mark T Dransfield,1 Nazmul Haque,2 Stephen Gleason,2 Katy A Hayes,2 Kenneth Kulmatycki,2 Denise P Yates,2 Henry Danahay,3 Martin Gosling,3,4 David J Rowlands,2 Sarah S Grant2 1University of Alabama at Birmingham, Departm
Externí odkaz:
https://doaj.org/article/7fca65db81524b9888847d498710aa20
Autor:
Dubaissi E; School of Biological Sciences, University of Manchester, Manchester, M13 9PT, UK.; Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, M13 9PT, UK.; Wellcome Centre for Cell Matrix Research, University of Manchester, Manchester, M13 9PT, UK.; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK., Hilton EN; School of Biological Sciences, University of Manchester, Manchester, M13 9PT, UK.; Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, M13 9PT, UK.; Wellcome Centre for Cell Matrix Research, University of Manchester, Manchester, M13 9PT, UK.; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK., Lilley S; Sussex Drug Discovery Centre, University of Sussex, Falmer, Brighton, BN1 9QJ, UK., Collins R; School of Biological Sciences, University of Manchester, Manchester, M13 9PT, UK.; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK., Holt C; School of Biological Sciences, University of Manchester, Manchester, M13 9PT, UK.; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK., March P; School of Biological Sciences, University of Manchester, Manchester, M13 9PT, UK.; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK., Danahay H; Enterprise Therapeutics, Sussex Innovation Centre, Science Park Square, Falmer, Brighton, BN1 9SB, UK., Gosling M; Sussex Drug Discovery Centre, University of Sussex, Falmer, Brighton, BN1 9QJ, UK.; Enterprise Therapeutics, Sussex Innovation Centre, Science Park Square, Falmer, Brighton, BN1 9SB, UK., Grencis RK; School of Biological Sciences, University of Manchester, Manchester, M13 9PT, UK.; Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, M13 9PT, UK.; Wellcome Centre for Cell Matrix Research, University of Manchester, Manchester, M13 9PT, UK.; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK., Roberts IS; School of Biological Sciences, University of Manchester, Manchester, M13 9PT, UK.; Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, M13 9PT, UK.; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK., Thornton DJ; School of Biological Sciences, University of Manchester, Manchester, M13 9PT, UK. dave.thornton@manchester.ac.uk.; Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, M13 9PT, UK. dave.thornton@manchester.ac.uk.; Wellcome Centre for Cell Matrix Research, University of Manchester, Manchester, M13 9PT, UK. dave.thornton@manchester.ac.uk.; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK. dave.thornton@manchester.ac.uk.
Publikováno v:
Scientific reports [Sci Rep] 2024 Oct 26; Vol. 14 (1), pp. 25555. Date of Electronic Publication: 2024 Oct 26.
Autor:
Danahay H; Enterprise Therapeutics Ltd, 60 Science Park Square, Brighton BN1 9SB, UK. Electronic address: henry@enterprisetherapeutics.com., McCarthy C; Enterprise Therapeutics Ltd, 60 Science Park Square, Brighton BN1 9SB, UK., Schofield T; Evotec UK Ltd, 114 Park Dr, Innovation Dr, Milton, Abingdon, OX14 4RZ, UK., Fox R; Sussex Drug Discovery Centre, School of Life Sciences, University of Sussex, Brighton, BN1 9RH, UK., Charlton H; Sussex Drug Discovery Centre, School of Life Sciences, University of Sussex, Brighton, BN1 9RH, UK., Lilley S; Sussex Drug Discovery Centre, School of Life Sciences, University of Sussex, Brighton, BN1 9RH, UK., Sabater J; Department of Research, Mount Sinai Medical Center, 4300 Alton Rd, Miami Beach, FL 33140, USA., Salathe M; Department of Internal Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA., Baumlin N; Department of Internal Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA., Collingwood SP; Enterprise Therapeutics Ltd, 60 Science Park Square, Brighton BN1 9SB, UK., Gosling M; Enterprise Therapeutics Ltd, 60 Science Park Square, Brighton BN1 9SB, UK.
Publikováno v:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2024 Jun 07. Date of Electronic Publication: 2024 Jun 07.
Autor:
Danahay H; Enterprise Therapeutics Ltd., Brighton, United Kingdom., Lilley S; Sussex Drug Discovery Centre, School of Life Sciences, University of Sussex, Brighton, United Kingdom., Adley K; Sussex Drug Discovery Centre, School of Life Sciences, University of Sussex, Brighton, United Kingdom., Charlton H; Sussex Drug Discovery Centre, School of Life Sciences, University of Sussex, Brighton, United Kingdom., Fox R; Sussex Drug Discovery Centre, School of Life Sciences, University of Sussex, Brighton, United Kingdom., Gosling M; Enterprise Therapeutics Ltd., Brighton, United Kingdom.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2023 Mar 06; Vol. 14, pp. 1142342. Date of Electronic Publication: 2023 Mar 06 (Print Publication: 2023).
Autor:
Danahay, H., Russell, P., Collingwood, S., Ford, J., Sabater, J., Charlwood, J., McCarthy, C., Gosling, M.
Publikováno v:
In Journal of Cystic Fibrosis June 2020 19 Supplement 2:S29-S29
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Grand DL; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Gosling M; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Baettig U; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Bahra P; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Bala K; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Brocklehurst C; Novartis Institutes for Biomedical Research, Novartis Campus, Basel, CH 4002, Switzerland., Budd E; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Butler R; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Cheung AK; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139, United States., Choudhury H; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Collingwood SP; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Cox B; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Danahay H; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Edwards L; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Everatt B; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Glaenzel U; Novartis Institutes for Biomedical Research, Novartis Campus, Basel, CH 4002, Switzerland., Glotin AL; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Groot-Kormelink P; Novartis Institutes for Biomedical Research, Novartis Campus, Basel, CH 4002, Switzerland., Hall E; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139, United States., Hatto J; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Howsham C; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Hughes G; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., King A; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Koehler J; Novartis Institutes for Biomedical Research, Novartis Campus, Basel, CH 4002, Switzerland., Kulkarni S; Novartis Institutes for Biomedical Research, East Hanover, New Jersey 07936, United States., Lightfoot M; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Nicholls I; Novartis Institutes for Biomedical Research, Novartis Campus, Basel, CH 4002, Switzerland., Page C; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Pergl-Wilson G; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Popa MO; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Robinson R; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139, United States., Rowlands D; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139, United States., Sharp T; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Spendiff M; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Stanley E; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Steward O; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Taylor RJ; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Tranter P; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Wagner T; Novartis Institutes for Biomedical Research, Novartis Campus, Basel, CH 4002, Switzerland., Watson H; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Williams G; Novartis Institutes for Biomedical Research, Novartis Campus, Basel, CH 4002, Switzerland., Wright P; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Young A; Novartis Institutes for Biomedical Research, Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, U.K., Sandham DA; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139, United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2021 Jun 10; Vol. 64 (11), pp. 7241-7260. Date of Electronic Publication: 2021 May 24.
Autor:
Panda, Kingshuk1 (AUTHOR) kpand014@fiu.edu, Santiago, Maria J.1,2 (AUTHOR) msant206@fiu.edu, Rahman, Md. Sohanur1 (AUTHOR) mdsrahma@fiu.edu, Ghorai, Suvankar1 (AUTHOR) sghorai@fiu.edu, Black, Stephen M.1,3 (AUTHOR) stblack@fiu.edu, Rahman, Irfan4 (AUTHOR) irfan_rahman@urmc.rochester.edu, Unwalla, Hoshang J.1 (AUTHOR) hunwalla@fiu.edu, Chinnapaiyan, Srinivasan1 (AUTHOR) hunwalla@fiu.edu
Publikováno v:
Cells (2073-4409). Dec2024, Vol. 13 Issue 23, p2009. 14p.
Autor:
Kazani S; Novartis Institutes for BioMedical Research, Cambridge, MA, United States; Novartis Institutes for BioMedical Research, Basel, Switzerland., Rowlands DJ; Novartis Institutes for BioMedical Research, Cambridge, MA, United States; Novartis Institutes for BioMedical Research, Basel, Switzerland., Bottoli I; Novartis Pharma AG, Basel, Switzerland. Electronic address: ivan.bottoli@novartis.com., Milojevic J; Novartis Institutes for BioMedical Research, Basel, Switzerland., Alcantara J; Novartis Institutes for BioMedical Research, Cambridge, MA, United States; Novartis Institutes for BioMedical Research, Basel, Switzerland., Jones I; Novartis Institutes for BioMedical Research, Cambridge, MA, United States; Novartis Institutes for BioMedical Research, Basel, Switzerland., Kulmatycki K; Novartis Institutes for BioMedical Research, Cambridge, MA, United States; Novartis Institutes for BioMedical Research, Basel, Switzerland., Machineni S; Novartis Healthcare Private Limited, Hyderabad, India., Mostovy L; Novartis Institutes for BioMedical Research, Cambridge, MA, United States; Novartis Institutes for BioMedical Research, Basel, Switzerland., Nicholls I; Novartis Institutes for BioMedical Research, Basel, Switzerland., Nick JA; National Jewish Health, Denver, CO, United States., Rowe SM; University of Alabama at Birmingham, Birmingham, AL, United States., Simmonds NJ; Adult Cystic Fibrosis Centre, Royal Brompton Hospital and Imperial College, London, United Kingdom., Vegesna R; Novartis Pharmaceuticals corporation, East Hanover, NJ, United States., Verheijen J; Novartis Institutes for BioMedical Research, Cambridge, MA, United States; Novartis Institutes for BioMedical Research, Basel, Switzerland., Danahay H; Enterprise Therapeutics, Brighton, United Kingdom., Gosling M; Novartis Pharmaceuticals corporation, East Hanover, NJ, United States; Enterprise Therapeutics, Brighton, United Kingdom; Sussex Drug Discovery Centre, University of Sussex, Brighton, United Kingdom., Ayalavajjala PS; Novartis Healthcare Private Limited, Hyderabad, India., Salman M; Novartis Healthcare Private Limited, Hyderabad, India., Strieter R; Novartis Institutes for BioMedical Research, Cambridge, MA, United States; Novartis Institutes for BioMedical Research, Basel, Switzerland.
Publikováno v:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2021 Mar; Vol. 20 (2), pp. 250-256. Date of Electronic Publication: 2020 Dec 06.